Skip to main content
Erschienen in: Neuroradiology 3/2009

01.03.2009 | Diagnostic Neuroradiology

Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel 1H-MRS at 1.5 T

verfasst von: Mikhail F. Chernov, Yoshihiro Muragaki, Takashi Maruyama, Yuko Ono, Masao Usukura, Shigetoshi Yoshida, Ryoichi Nakamura, Hiroshi Iseki, Osami Kubo, Tomokatsu Hori, Kintomo Takakura

Erschienen in: Neuroradiology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Introduction

The present study was done for evaluation of the possible influence of the oral administration of choline on metabolic characteristics of gliomas detected with proton magnetic resonance spectroscopy (1H-MRS).

Materials and methods

Thirty patients (22 men and eight women; mean age 38 ± 15 years) with suspicious intracranial gliomas underwent single-voxel long-echo (TR 2,000 ms, TE 136 ms, 128–256 acquisitions) 1H-MRS of the tumor, peritumoral brain tissue, and distant normal-appearing white matter before and several hours (median, 3 h; range, 1.2–3.7 h) after ingestion of choline with prescribed dose of 50 mg/kg (median actual dose, 52 mg/kg; range, 48–78 mg/kg). Investigations were done using 1.5 T clinical magnetic resonance imager. The volume of the rectangular 1H-MRS voxel was either 3.4 or 8 cm3. At the time of both spectroscopic examinations, similar voxels’ positioning and size and technical parameters of 1H-MRS were used. Surgery was done in 27 patients within 1 to 68 days thereafter. In all cases, more than 80% resection of the neoplasm was attained.

Results

There were 12 low-grade gliomas and 15 high-grade gliomas. MIB-1 index varied from 0% to 51.7% (median, 13.8%). Statistical analysis did not disclose significant differences of any investigated metabolic parameter of the tumor, peritumoral brain tissue and distant normal-appearing white matter between two spectroscopic examinations.

Conclusion

Single-voxel 1H-MRS at 1.5 T could not detect significant changes of the metabolic characteristics of gliomas, peritumoral brain tissue, and distant normal-appearing white matter after oral administration of choline.
Literatur
1.
Zurück zum Zitat Moller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371–381, doi:10.1007/s00234-001-0760-0 PubMedCrossRef Moller-Hartmann W, Herminghaus S, Krings T, Marquardt G, Lanfermann H, Pilatus U, Zanella FE (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371–381, doi:10.​1007/​s00234-001-0760-0 PubMedCrossRef
4.
Zurück zum Zitat Chinn RJS, Wilkinson ID, Hall-Craggs MA, Paley MNJ, Miller RF, Kendall BE, Newman SP, Harrison MJG (1995) Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 197:649–654PubMed Chinn RJS, Wilkinson ID, Hall-Craggs MA, Paley MNJ, Miller RF, Kendall BE, Newman SP, Harrison MJG (1995) Toxoplasmosis and primary central nervous system lymphoma in HIV infection: diagnosis with MR spectroscopy. Radiology 197:649–654PubMed
5.
Zurück zum Zitat Simone IL, Federico F, Tortorella C, Andreula CF, Zimatore GB, Giannini P, Angarano G, Lucivero V, Picciola P, Carrara D, Bellacosa A, Livrea P (1998) Localised 1H-MR spectroscopy for metabolic characterization of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 64:516–523PubMedCrossRef Simone IL, Federico F, Tortorella C, Andreula CF, Zimatore GB, Giannini P, Angarano G, Lucivero V, Picciola P, Carrara D, Bellacosa A, Livrea P (1998) Localised 1H-MR spectroscopy for metabolic characterization of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 64:516–523PubMedCrossRef
7.
Zurück zum Zitat Park SW, Chang KH, Kim HD, Song IC, Lee DS, Lee SK, Chung CK, Yu IK, Han MH, Park YH (2001) Lateralizing ability of single-voxel proton MR spectroscopy in hippocampal sclerosis: comparison with MR imaging and positron emission tomography. AJNR Am J Neuroradiol 22:625–631PubMed Park SW, Chang KH, Kim HD, Song IC, Lee DS, Lee SK, Chung CK, Yu IK, Han MH, Park YH (2001) Lateralizing ability of single-voxel proton MR spectroscopy in hippocampal sclerosis: comparison with MR imaging and positron emission tomography. AJNR Am J Neuroradiol 22:625–631PubMed
8.
Zurück zum Zitat Butteriss DJA, Ismail A, Ellison DW, Birchall D (2003) Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol 76:662–665, doi:10.1259/bjr/85069069 PubMedCrossRef Butteriss DJA, Ismail A, Ellison DW, Birchall D (2003) Use of serial proton magnetic resonance spectroscopy to differentiate low grade glioma from tumefactive plaque in a patient with multiple sclerosis. Br J Radiol 76:662–665, doi:10.​1259/​bjr/​85069069 PubMedCrossRef
9.
Zurück zum Zitat Mader I, Rauer S, Gall P, Klose U (2008) 1H MR spectroscopy of inflammation, infection, and ischemia of the brain. Eur J Radiol 67:250–257PubMedCrossRef Mader I, Rauer S, Gall P, Klose U (2008) 1H MR spectroscopy of inflammation, infection, and ischemia of the brain. Eur J Radiol 67:250–257PubMedCrossRef
10.
Zurück zum Zitat Stoll AL, Renshaw PF, De Micheli E, Wurtman R, Pillay SS, Cohen BM (1995) Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiatry 37:170–174, doi:10.1016/0006-3223(94)00120-R PubMedCrossRef Stoll AL, Renshaw PF, De Micheli E, Wurtman R, Pillay SS, Cohen BM (1995) Choline ingestion increases the resonance of choline-containing compounds in human brain: an in vivo proton magnetic resonance study. Biol Psychiatry 37:170–174, doi:10.​1016/​0006-3223(94)00120-R PubMedCrossRef
12.
Zurück zum Zitat Hara T, Kosaka N, Shinoura N, Kondo T (1997) PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 38:842–847PubMed Hara T, Kosaka N, Shinoura N, Kondo T (1997) PET imaging of brain tumor with [methyl-11C]choline. J Nucl Med 38:842–847PubMed
13.
Zurück zum Zitat Hara T, Kondo T, Hara T, Kosaka N (2003) Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 99:474–479PubMedCrossRef Hara T, Kondo T, Hara T, Kosaka N (2003) Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas. J Neurosurg 99:474–479PubMedCrossRef
14.
Zurück zum Zitat Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, Utriainen T, Roivainen A, Kalimo H, Minn H (2003) Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol 62:329–338, doi:10.1023/A:1023342516925 PubMedCrossRef Utriainen M, Komu M, Vuorinen V, Lehikoinen P, Sonninen P, Kurki T, Utriainen T, Roivainen A, Kalimo H, Minn H (2003) Evaluation of brain tumor metabolism with [11C]choline PET and 1H-MRS. J Neurooncol 62:329–338, doi:10.​1023/​A:​1023342516925 PubMedCrossRef
16.
Zurück zum Zitat Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T (2008) Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29:1176–1182, doi:10.3174/ajnr.A1008 PubMedCrossRef Kato T, Shinoda J, Nakayama N, Miwa K, Okumura A, Yano H, Yoshimura S, Maruyama T, Muragaki Y, Iwama T (2008) Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. AJNR Am J Neuroradiol 29:1176–1182, doi:10.​3174/​ajnr.​A1008 PubMedCrossRef
17.
Zurück zum Zitat Kleihues P, Cavenee WK (eds) (2000) In: Pathology and genetics of tumours of the nervous system. IARC, Lyon Kleihues P, Cavenee WK (eds) (2000) In: Pathology and genetics of tumours of the nervous system. IARC, Lyon
18.
Zurück zum Zitat Rand SD, Prost R, Li SJ (1999) Proton MR spectroscopy of the brain. Neuroimaging Clin N Am 9:379–395PubMed Rand SD, Prost R, Li SJ (1999) Proton MR spectroscopy of the brain. Neuroimaging Clin N Am 9:379–395PubMed
19.
Zurück zum Zitat Tan J, Bluml S, Hoang T, Dubowitz D, Mevenkamp G, Ross B (1998) Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain. Magn Reson Med 39:1005–1010, doi:10.1002/mrm.1910390619 PubMedCrossRef Tan J, Bluml S, Hoang T, Dubowitz D, Mevenkamp G, Ross B (1998) Lack of effect of oral choline supplement on the concentrations of choline metabolites in human brain. Magn Reson Med 39:1005–1010, doi:10.​1002/​mrm.​1910390619 PubMedCrossRef
Metadaten
Titel
Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel 1H-MRS at 1.5 T
verfasst von
Mikhail F. Chernov
Yoshihiro Muragaki
Takashi Maruyama
Yuko Ono
Masao Usukura
Shigetoshi Yoshida
Ryoichi Nakamura
Hiroshi Iseki
Osami Kubo
Tomokatsu Hori
Kintomo Takakura
Publikationsdatum
01.03.2009
Verlag
Springer-Verlag
Erschienen in
Neuroradiology / Ausgabe 3/2009
Print ISSN: 0028-3940
Elektronische ISSN: 1432-1920
DOI
https://doi.org/10.1007/s00234-008-0471-x

Weitere Artikel der Ausgabe 3/2009

Neuroradiology 3/2009 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.